INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2018 |
Sep. 30, 2017 |
Sep. 30, 2018 |
Sep. 30, 2017 |
|
| Operating expenses: | ||||
| Research and development, net | $ 1,975 | $ 1,168 | $ 4,433 | $ 2,544 |
| General and administrative | 1,257 | 1,224 | 4,193 | 2,693 |
| Operating loss | (3,232) | (2,392) | (8,626) | (5,237) |
| Financial expenses (income), net | (56) | 11 | (61) | (9) |
| Net loss | $ (3,176) | $ (2,403) | $ (8,565) | $ (5,228) |
| Basic and diluted net loss per share from continuing operations | $ (0.15) | $ (0.13) | $ (0.43) | $ (0.28) |
| Weighted average number of shares outstanding used in computing basic and diluted net loss per share | 20,691,900 | 18,783,997 | 19,754,159 | 18,737,307 |